Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring
            KIT
            Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10‐06)

Su Jin Lee; Tae Min Kim; Yu Jung Kim; Kee‐Taek Jang; Hyo Jin Lee; Soon Nam Lee; Mi Sun Ahn; In Gyu Hwang; Suee Lee; Moon‐Hee Lee; Jeeyun Lee

doi:10.1634/theoncologist.2015-0161

Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10‐06)

The Oncologist ◽

10.1634/theoncologist.2015-0161 ◽

2015 ◽

Vol 20 (11) ◽

pp. 1312-1319 ◽

Cited By ~ 30

Author(s):

Su Jin Lee ◽

Tae Min Kim ◽

Yu Jung Kim ◽

Kee‐Taek Jang ◽

Hyo Jin Lee ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Malignant Melanoma ◽

Multicenter Trial ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Kit Gene

Download Full-text

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-018-2752-z ◽

2018 ◽

Vol 145 (3) ◽

pp. 717-723 ◽

Cited By ~ 16

Author(s):

Martin Fenner ◽

Christoph Oing ◽

Annette Dieing ◽

Thomas Gauler ◽

Karin Oechsle ◽

...

Keyword(s):

Testicular Cancer ◽

Germ Cell ◽

Phase Ii ◽

Germ Cell Tumors ◽

Multicenter Trial ◽

Study Group ◽

Open Label ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

P3-16-06: Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03].

10.1158/0008-5472.sabcs11-p3-16-06 ◽

2011 ◽

Author(s):

S-A Im ◽

D-Y Oh ◽

KS Lee ◽

J-H Ahn ◽

J Shon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Previously Treated ◽

Taxane Chemotherapy

Download Full-text

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)☆

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.10.053 ◽

2007 ◽

Vol 105 (1) ◽

pp. 132-137 ◽

Cited By ~ 67

Author(s):

U WAGNER ◽

A DUBOIS ◽

J PFISTERER ◽

J HUOBER ◽

S LOIBL ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03]

Annals of Oncology ◽

10.1016/s0923-7534(20)31962-1 ◽

2012 ◽

Vol 23 ◽

pp. xi18

Author(s):

S.-A. Im ◽

K.H. Lee ◽

D.-Y. Oh ◽

K.S. Lee ◽

J.-H. Ahn ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Previously Treated ◽

Taxane Chemotherapy

Download Full-text

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of Oncology ◽

10.1093/annonc/mdz260.051 ◽

2019 ◽

Vol 30 ◽

pp. v628

Author(s):

T.M. Kim ◽

C.-Y. Ock ◽

M. Kim ◽

S.H. Kim ◽

B. Keam ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Multicenter Trial ◽

Insertion Mutation ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Exon 20 ◽

Nsclc Patients

Download Full-text

Updated Analysis: Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients with Metastatic Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group (HGCSG) Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)32186-4 ◽

2012 ◽

Vol 23 ◽

pp. xi82

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Nakatsumi ◽

Y. Kobayashi ◽

S. Takeuchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Combined Chemotherapy ◽

Cancer Study ◽

Cancer Study Group ◽

Analysis Phase

Download Full-text

Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

Cancer ◽

10.1002/1097-0142(19820515)49:10<2192::aid-cncr2820491035>3.0.co;2-r ◽

1982 ◽

Vol 49 (10) ◽

pp. 2192-2196 ◽

Cited By ~ 42

Author(s):

Gary A. Presant ◽

Alfred A. Bartolucci ◽

Keyword(s):

Prognostic Factors ◽

Malignant Melanoma ◽

Metastatic Malignant Melanoma ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Group Experience

Download Full-text

Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group

International Journal of Cancer ◽

10.1002/ijc.33696 ◽

2021 ◽

Author(s):

Ralf‐Dieter Hofheinz ◽

Susanne Hegewisch‐Becker ◽

Volker Kunzmann ◽

Peter Thuss‐Patience ◽

Martin Fuchs ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Study Group ◽

Her2 Positive ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Cancer Study ◽

Esophagogastric Adenocarcinoma

Download Full-text

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Case Medical Research ◽

10.31525/ct1-nct04230759 ◽

2020 ◽

Author(s):

Keyword(s):

Phase Ii ◽

Anal Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Anal Carcinoma ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Randomized Phase Ii

Download Full-text

HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4073 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4073-4073 ◽

Cited By ~ 19

Author(s):

Ralf Hofheinz ◽

Susanna Hegewisch-Becker ◽

Peter C. Thuss-Patience ◽

Volker Kunzmann ◽

Martin Fuchs ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Study Group ◽

Her2 Positive ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Cancer Study ◽

Esophagogastric Adenocarcinoma

Download Full-text